(Q43908319)

27 November 2017

title

Mechanisms of alpha1-antitrypsin inhibition of cellular serine proteases and HIV-1 protease that are essential for HIV-1 morphogenesis (English)

1 reference

27 November 2017

1 reference

Pierre Cordelier

1

1 reference

27 November 2017

David S Strayer

series ordinal

2

1 reference

27 November 2017

language of work or name

1 reference

1 July 2003

1 reference

Biochimica et Biophysica Acta

27 November 2017

published in

1 reference

27 November 2017

volume

1638

1 reference

27 November 2017

issue

3

1 reference

27 November 2017

page(s)

197-207

1 reference

Standardized and simplified nomenclature for proteins common to all retroviruses

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2803%2900084-X

7 January 2021

Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2803%2900084-X

7 January 2021

The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2803%2900084-X

7 January 2021

Processing of the structural proteins of human immunodeficiency virus type 1 in the presence of monensin and cerulenin

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2803%2900084-X

7 January 2021

Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2803%2900084-X

7 January 2021

HIV-1 proprotein processing as a target for gene therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2803%2900084-X

7 January 2021

Inhibition of HIV-1 by an anti-integrase single-chain variable fragment (SFv): delivery by SV40 provides durable protection against HIV-1 and does not require selection

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2803%2900084-X

7 January 2021

Titering replication-defective virus for use in gene transfer.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2803%2900084-X

7 January 2021

A novel SV40-based vector successfully transduces and expresses an alpha 1-antitrypsin ribozyme in a human hepatoma-derived cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2803%2900084-X

7 January 2021

Use of SV40 to immunize against hepatitis B surface antigen: implications for the use of SV40 for gene transduction and its use as an immunizing agent

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2803%2900084-X

7 January 2021

Human immunodeficiency viral protease is catalytically active as a fusion protein: characterization of the fusion and native enzymes produced in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2803%2900084-X

7 January 2021

Conserved cysteines of the human immunodeficiency virus type 1 protease are involved in regulation of polyprotein processing and viral maturation of immature virions

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2803%2900084-X

7 January 2021

alpha1-Antitrypsin Portland, a bioengineered serpin highly selective for furin: application as an antipathogenic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2803%2900084-X

7 January 2021

Cloning and sequence of cDNA coding for alpha 1-antitrypsin

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2803%2900084-X

7 January 2021

Caffeine-induced Ca2+ release activates Ca2+ extrusion via Na+-Ca2+ exchanger in cardiac myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2803%2900084-X

7 January 2021

Conformational changes in serpins: II. The mechanism of activation of antithrombin by heparin.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2803%2900084-X

7 January 2021

Conformational changes in serpins: I. the native and cleaved conformations of α 1 -antitrypsin 1 1Edited by J. M. Thornton

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2803%2900084-X

7 January 2021

Structure of a serpin-protease complex shows inhibition by deformation

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2803%2900084-X

7 January 2021

Formation of the covalent chymotrypsin.antichymotrypsin complex involves no large-scale movement of the enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2803%2900084-X

7 January 2021

Alpha1-antitrypsin Portland inhibits processing of precursors mediated by proprotein convertases primarily within the constitutive secretory pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2803%2900084-X

7 January 2021

Biochemical and genetic definition of the cellular protease required for HIV-1 gp160 processing

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2803%2900084-X

7 January 2021

Maturation of HIV envelope glycoprotein precursors by cellular endoproteases

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2803%2900084-X

7 January 2021

Proteolytic processing of polyproteins in the replication of RNA viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2803%2900084-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0925-4439%2803%2900084-X

1 reference

7 January 2021

Active human immunodeficiency virus protease is required for viral infectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2803%2900084-X

7 January 2021

Complete mutagenesis of the HIV-1 protease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2803%2900084-X

7 January 2021

A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2803%2900084-X

7 January 2021

HIV-1 protease as a potential target for anti-AIDS therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2803%2900084-X

7 January 2021

Rational design of peptide-based HIV proteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2803%2900084-X

7 January 2021

Amino-terminal polypeptides of vimentin are responsible for the changes in nuclear architecture associated with human immunodeficiency virus type 1 protease activity in tissue culture cells

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2803%2900084-X

7 January 2021

Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2803%2900084-X

7 January 2021

10.1016/S0925-4439(03)00084-X

Identifiers

DOI

1 reference

27 November 2017

1 reference